Dosify Pharmaceutical Private Limited
About Dosify Pharmaceutical Private Limited
Data last updated:
Dosify Pharmaceutical Private Limited is a private limited company based in Neemuch, Madhya Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 26 May 2022.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U51909MP2022PTC061096.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Abhinav Chaurasia and Garima Sisodia.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 09 Seediyam, Neemuch, Madhya Pradesh, India – 458441.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.71 Cr, a growth of 45% compared to the previous year. For the same year it recorded a net profit of ₹9.54 Lakh (net margin 3.5%) and EBITDA of ₹9.7 Lakh (EBITDA margin 3.6%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address09 Seediyam, Neemuch, Madhya Pradesh, India – 458441
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Dosify Pharmaceutical Private Limited FY 2025 filings available
Dosify Pharmaceutical Private Limited reported revenue of ₹2.71 Cr (up 45% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Dosify Pharmaceutical Private Limited
Revenue rose 45% in the latest year. EBITDA rose 271% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Dosify Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | ₹9.7 Lakh | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | ₹9.54 Lakh | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Dosify Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 3.6% | •••• | •••• |
| Net Profit Margin | 3.5% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Dosify Pharmaceutical are in the company report.
Financial statements from FY 2023
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Dosify Pharmaceutical Private Limited
Dosify Pharmaceutical has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Abhinav Chaurasia Also directs: Aarambh E-Services Private Limited | Director | 26 May 2022 | 4 Years 4 Months | Current |
| Garima Sisodia Also directs: Aarambh E-Services Private Limited | Director | 29 Feb 2024 | 2 Years 7 Months | Current |
Charges & Borrowings of Dosify Pharmaceutical Private Limited
Dosify Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Dosify Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Dosify Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Dosify Pharmaceutical Private Limited
Dosify Pharmaceutical Private Limited has 3 board changes on record since 2022: 2 appointments and 1 cessation. The latest: Sumeet Gaikwad ceased to be Director on 01 Mar 2024.
Credit Ratings, Litigation & Regulatory Alerts for Dosify Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Dosify Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Dosify Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Dosify Pharmaceutical Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Dosify Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dosify Pharmaceutical Private Limited
Dosify Pharmaceutical is an active private limited company based in Neemuch, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 26 May 2022 (4+ years old) and is registered under CIN U51909MP2022PTC061096.
Dosify Pharmaceutical reported revenue of ₹2.71 Cr for FY 2025 (up 45% YoY).
Dosify Pharmaceutical has 2 current directors:
- Abhinav Chaurasia - Director
- Garima Sisodia - Director
Dosify Pharmaceutical reported a net profit of ₹9.54 Lakh (net margin 3.5%) and EBITDA of ₹9.7 Lakh (EBITDA margin 3.6%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Dosify Pharmaceutical is U51909MP2022PTC061096. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dosify Pharmaceutical was incorporated on 26 May 2022, making it 4+ years old. It is registered with the Registrar of Companies, Gwalior.
Sumeet Gaikwad ceased to be Director on 01 Mar 2024. Garima Sisodia was appointed as Director on 29 Feb 2024. Abhinav Chaurasia was appointed as Director on 26 May 2022.
The registered office of Dosify Pharmaceutical is at 09 Seediyam, Neemuch, Madhya Pradesh, India – 458441.
Dosify Pharmaceutical has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh.
Dosify Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.